Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7271)
All Articles published online
|
Publishing Process of This Article
|
Nov 18, 2016 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Carrier P, Essig M, Debette-Gratien M, Sautereau D, Rousseau A, Marquet P, Jacques J, Loustaud-Ratti V. Anti-hepatitis C virus drugs and kidney. World J Hepatol 2016; 8(32): 1343-1353 [PMID: 27917261 DOI: 10.4254/wjh.v8.i32.1343] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v8/i32/1343.htm |
| Number | Citing Articles |
| 1 |
Aalam Sohal, Carol Singh, Akshita Bhalla, Harsimran Kalsi, Marina Roytman. Renal Manifestations of Chronic Hepatitis C: A Review. Journal of Clinical Medicine 2024; 13(18): 5536 doi: 10.3390/jcm13185536
|
| 2 |
Jianhong Chen, Xiaxia Zhang, Hao Luo, Chihong Wu, Min Yu, Dan Liu, Hongli Xi, Yihang Zhou, Yaoyu An, Xiaoyuan Xu. Changes in renal function indices in cirrhotic chronic hepatitis C patients treated with sofosbuvir-containing regimens. Oncotarget 2017; 8(53): 90916 doi: 10.18632/oncotarget.18701
|
| 3 |
E. Novel Catin, S. Durupt, L. de Laforcade, M. Lecoq, I. Durieu, Q. Reynaud. Acute kidney injury, a rare complication of acute hepatitis E infection. Médecine et Maladies Infectieuses 2017; 47(7): 502 doi: 10.1016/j.medmal.2017.05.006
|
| 4 |
Che-Pin Chang, Yuan-Chih Su, Mei-Chen Lin, Sheng-Teng Huang. Chinese Herbal Medicine Ameliorated the Development of Chronic Kidney Disease in Patients with Chronic Hepatitis C: A Retrospective Population-Based Cohort Study. Evidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/5319456
|
| 5 |
M. J. Álvarez‐Ossorio, R. Sarmento e Castro, R. Granados, J. Macías, L. E. Morano‐Amado, M. J. Ríos, D. Merino, E. N. Álvarez, A. Collado, M. Pérez‐Pérez, F. Téllez, J. M. Martín, J. Méndez, J. A. Pineda, K. Neukam. Impact of interferon‐free regimens on the glomerular filtration rate during treatment of chronic hepatitis C in a real‐life cohort. Journal of Viral Hepatitis 2018; 25(6): 699 doi: 10.1111/jvh.12867
|
| 6 |
Gerson Dierley Keppeke, S. John Calise, Edward K.L. Chan, Luis Eduardo C. Andrade. Ribavirin induces widespread accumulation of IMP dehydrogenase into rods/rings structures in multiple major mouse organs. Antiviral Research 2019; 162: 130 doi: 10.1016/j.antiviral.2018.12.017
|
| 7 |
Alessio Strazzulla, Giuseppe Coppolino, Giorgio Settimo Barreca, Innocenza Gentile, Laura Rivoli, Maria Concetta Postorino, Maria Mazzitelli, Giuseppe Greco, Chiara Costa, Vincenzo Pisani, Nadia Marascio, Mariadelina Simeoni, Alfredo Focà, Giorgio Fuiano, Daniela Foti, Elio Gulletta, Carlo Torti. Evolution of glomerular filtration rates and neutrophil gelatinase-associated lipocalin during treatment with direct acting antivirals. Clinical and Molecular Hepatology 2018; 24(2): 151 doi: 10.3350/cmh.2017.0059
|
| 8 |
Hongfeng Huang, Huanna Tang, Hao Deng, Jia Shen, Qin Zhou, Wenqing Xie, Jianyong Wu, Jianghua Chen. Treatment of chronic hepatitis C viral infection with sofosbuvir and daclatasvir in kidney transplant recipients. Transplant Infectious Disease 2019; 21(1) doi: 10.1111/tid.13018
|
| 9 |
Lucia Taramasso, Antonio Di Biagio, Francesca Bovis, Laura Ambra Nicolini, Andrea Antinori, Laura Milazzo, Salvatore Sollima, Guido Gubertini, Fosca Niero, Annalisa Saracino, Raffaele Bruno, Vanni Borghi, Francesca Montagnani, Annamaria Cattelan, Hamid Hasson, Gloria Taliani, Antonella D’Arminio Monforte, Claudio Mastroianni, Giovanni Di Perri, Sara Bigoni, Massimo Puoti, Angiola Spinetti, Andrea Gori, Nicola Boffa, Bruno Cacopardo, Andrea Giacometti, Giustino Parruti, Vincenzo Vullo, Antonio Chirianni, Elisabetta Teti, Caterina Pasquazzi, Daniela Segala, Massimo Andreoni, Chen-Hua Liu. Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients. PLOS ONE 2018; 13(2): e0192627 doi: 10.1371/journal.pone.0192627
|
| 10 |
Ali Nada, Mohamed Abbasy, Aliaa Sabry, Azza Mohamed Abdu Allah, Somaia Shehab-Eldeen, Nada Elnaidany, Hanan Elimam, Kawthar Ibraheem Mohamed Ibraheem, Abdallah Essa. Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) in HCV-Positive Egyptian Patients Treated with Sofosbuvir. Canadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/1632959
|
| 11 |
Mahmood Danishwar, Zahid Jamil, Salman Khan, Michael Nakhla, Ishtiaq Ahmad, Muhammad Ashar Ali, Daryl T. Y. Lau. Persistence of Cryoglobulinemic Vasculitis after DAA Induced HCV Cure. Journal of Clinical Medicine 2022; 11(4): 984 doi: 10.3390/jcm11040984
|
| 12 |
Chunhong Li, Jing Liang, Huiling Xiang, Haiyan Chen, Jie Tian. Effectiveness of direct-acting antivirals in maintenance hemodialysis patients complicated with chronic hepatitis C. Medicine 2020; 99(48): e23384 doi: 10.1097/MD.0000000000023384
|
| 13 |
Rosanna Villani, Antonino Davide Romano, Moris Sangineto, Gaetano Serviddio. Direct-acting antivirals improve kidney function in diabetic patients with HCV infection and chronic kidney disease. Internal and Emergency Medicine 2021; 16(5): 1239 doi: 10.1007/s11739-020-02628-1
|
| 14 |
Mayssa El Raziky, Sherif Hamdy, Yasser Hamada, Nermin Mohamed Abdelaziz, Mohamed Hassany, Wahid Doss, Zeinab Zakaria. Efficacy and safety of sofosbuvir and daclatasvir in patients with chronic hepatitis C virus induced cirrhosis with Child-Pugh class B. Egyptian Liver Journal 2022; 12(1) doi: 10.1186/s43066-022-00174-3
|